Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3680033013 | Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3680035018 | Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Is a | Product containing lamivudine and nevirapine and zidovudine (medicinal product) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has active ingredient | Zidovudine (substance) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has active ingredient | Lamivudine (substance) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has active ingredient | Nevirapine (substance) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Is a | Product containing zidovudine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Is a | Lamivudine- and nevirapine- and zidovudine-containing product in oral dose form | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has active ingredient | Lamivudine (substance) | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has basis of strength substance (attribute) | Lamivudine (substance) | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has active ingredient | Zidovudine (substance) | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has basis of strength substance (attribute) | Zidovudine (substance) | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has active ingredient | Nevirapine (substance) | false | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has basis of strength substance (attribute) | Nevirapine (substance) | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has precise active ingredient | Zidovudine (substance) | false | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has precise active ingredient | Lamivudine (substance) | false | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has precise active ingredient | Nevirapine (substance) | true | Inferred relationship | Some | 2 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Is a | Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has basis of strength substance (attribute) | Zidovudine (substance) | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has basis of strength substance (attribute) | Lamivudine (substance) | true | Inferred relationship | Some | 1 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has precise active ingredient | Zidovudine (substance) | true | Inferred relationship | Some | 3 | |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet | Has precise active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets